Shinya Kimura

17PUBLICATIONS
57CO-AUTHORS
Predictive and prognostic markersHaematological tumoursRegenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 28, 2026
Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial.

|Dec 10, 2025
Prospective isolation of mouse and human hematopoietic stem cells using PLXDC2.

Yosuke Tanaka, Yasushi Kubota, Riko Kikuchi

|Sep 16, 2025
Granulocyte abundance and maturation state at diagnosis predicts treatment-free remission in CML.

Mikko Purhonen, Mikael Tatun, Katariina Luukkainen

|Aug 11, 2025
Clinical Features and T-Cell Repertoire of Chronic Myeloid Leukemia Patients Who Attempt Discontinuation of Tyrosine Kinase Inhibitors: The ISAC-TFR Study.

Hiroshi Ureshino, Yukio Nakamura, Yemima Budirahardja

|Jan 21, 2025
Treating Hematological Malignancies With OR-2100, an Orally Bioavailable Prodrug of Decitabine.

Tatsuro Watanabe, Keisuke Kidoguchi, Shinya Kimura

|Jun 05, 2024
DNA demethylating agents for chemoprevention of oncovirus-associated leukemogenesis.

Yuta Yamamoto, Tatsuro Watanabe, Hiroshi Ureshino

Pageof 3

Frequent Collaborators

6 joint publications

Hiroshi Ureshino

3 joint publications

Tatsuro Watanabe

2 joint publications

Kensuke Usuki

2 joint publications

Junya Kuroda